Health product recalls and alerts, 2002
38 notices, newest first. Each links to the official notice.
Drugs, vaccines and biologics
- Archived – Important Safety Information regarding Bextra (valdecoxib) – Pharmacia and PfizerDecember 31, 2002 · Drugs · Product safety
- Archived – Important Safety Concerns on the Use of Diane-35December 19, 2002 · Drugs · Product safety
- Archived – Important Safety Information Regarding Accolate® (Zafirlukast) and Hepatic Effects – AstraZenecaDecember 18, 2002 · Drugs · Product safety
- Archived - Public Advisory: Liver Problems Associated With Use of ACCOLATE (zafirlukast) in Some Patients - AstraZeneca - For the PublicDecember 18, 2002 · Drugs
- Archived – Use of Kineret®(anakinra) in Combination with EtanerceptDecember 17, 2002 · Biologic or vaccine · New safety information
- Archived – Important Safety Information: Use of Kineret (Anakinra) in Combination with Etanercept – Amgen Canada – For the PublicDecember 17, 2002 · Biologic or vaccine · Product safety
- Archived – Important Safety Information Regarding Tamoxifen and Incidence of Uterine Malignancies, Stroke and Pulmonary EmbolismNovember 7, 2002 · Drugs · Product safety
- Archived - Important Drug Warning - Videx-Zerit - Bristol-Myers SquibbNovember 1, 2002 · Drugs
- Archived – Important Safety Information Regarding Medication Errors Resulting From Confusion Between Seroquel and Serzone-5HT2 – AstraZeneca and Bristol-Myers Squibb – For the PublicOctober 31, 2002 · Drugs · Product safety
- Archived – Important Safety Information Regarding Medication Errors Resulting from Confusion Between Seroquel® and Serzone-5HT2® – AstraZeneca and Bristol-Myers SquibbOctober 31, 2002 · Drugs · Product safety
- Archived – Important Safety Information regarding Refludan® – Berlex Canada Inc.October 30, 2002 · Biologic or vaccine · Product safety
- Archived – Urgent Vaccine Recall – Voluntary Recall of Single Dose Menomune®: A/C/Y/W-135 (Meningococcal Polysaccharide Vaccine, Groups A, C, Y and W-135 Combined) – Aventis PasteurOctober 22, 2002 · Biologic or vaccine · New safety information
- Archived – Updated Safety Information for Risperdal (Risperidone) in Elderly Dementia Patients, Announced in Canada by Janssen-Ortho Inc. – For the PublicOctober 17, 2002 · Drugs · Product safety
- Archived – Important Drug Safety Information: Risperdal (Risperidone) and Cerebrovascular Adverse Events in Placebo-Controlled Dementia Trials – Janssen-Ortho Inc.October 11, 2002 · Drugs · Product safety
- Archived – Risks Associated with Soft Tissues from Cryolife Inc. Used for TransplantationAugust 27, 2002 · Biologic or vaccine · New safety information
- Archived – Important Update Regarding Indications for Aspirin®August 8, 2002 · Drugs · Product safety
- Archived – Important Drug Safety Update for Patients Using Matulane® (Procarbazine Hydrochloride) Capsules (Formerly Marketed Under the Name Natulan®) – Sigma-Tau Pharmaceuticals, Inc. – Consumer InformationJuly 18, 2002 · Drugs · Product safety
- Archived – Propofol Contraindicated for Sedation in Pediatric Patients Receiving Intensive CareJuly 10, 2002 · Drugs · New safety information
- Archived – Safety Update: Updated Information About EPREX (epoetin alfa) Provided to Canadian Healthcare Professionals – Janssen-Ortho Inc. and Ortho Biotech – For the PublicJuly 4, 2002 · Biologic or vaccine · New safety information
- Archived – Important Safety Information Regarding Lioresal Intrathecal (Baclofen)July 1, 2002 · Drugs · Product safety
- Archived – EPREX (Epoetin Alfa) – Pure Red Cell Aplasia (PRCA, Erythroblastopenia)June 25, 2002 · Drugs · Product safety
- Archived – Important Drug Warning – Garasone / Garamycin – Schering Canada Inc.May 30, 2002 · Drugs · Product safety
- Archived – Important Safety Information – PLAS+SD PLASMA (Human) – Precision Pharma Services Inc.May 16, 2002 · Biologic or vaccine · Product safety
- Archived – Important Drug Safety Information on Rapamune® – Wyeth-Ayerst Canada Inc.May 14, 2002 · Drugs · Product safety
- Archived – Important Drug Safety Information on Celebrex – Pharmacia Canada Inc. and Pfizer Canada Inc.May 13, 2002 · Drugs · Product safety
- Archived – Important Drug Safety Information on VIOXX® – Merck Frosst Canada Inc.April 15, 2002 · Drugs · Product safety
- Archived – Thrombotic Events and Immune Globulin Intravenous (IGIV) – BaxterApril 12, 2002 · Biologic or vaccine · Product safety
- Archived – Symptoms Mimicking the Clinical Presentation of Guillain-Barré Syndrome Associated with ZERIT® (stavudine, d4T) – Bristol-Myers SquibbMarch 6, 2002 · Drugs · Product safety
- Archived – Cardiovascular Toxicity with Injectable DroperidolFebruary 12, 2002 · Drugs · Product safety
- Archived – Risk of Cardiovascular Toxicity Associated with Schizophrenia Medication Clozapine – For the PublicJanuary 18, 2002 · Drugs · Product safety
- Archived – Association of Clozaril (Clozapine) with Cardiovascular Toxicity – NovartisJanuary 14, 2002 · Drugs · Product safety
Natural health products
- Archived – Important Safety Information Regarding Sodium Phosphates Oral Solution – Pharmascience Inc.March 18, 2002 · Natural health products · Product safety
- Archived – Important Safety Information Regarding Fleet® Phospho-Soda® (Sodium Phosphates Oral Solution) – Johnson & Johnson - MerckMarch 15, 2002 · Natural health products · Product safety
Medical devices
- Archived – Risk of Strangulation of Infants by IV Tubing and Monitor LeadsJuly 30, 2002 · Medical devices · New safety information
- Archived – Cochlear Implant Recipients may be at Greater Risk for MeningitisJuly 29, 2002 · Medical devices · Product safety
- Archived - Fast-Check HIV-1/2 (serum) & Fast-Check HIV-1/2 (whole blood) manufactured by BioChem ImmunoSystems Inc.April 29, 2002 · Medical devices
- Archived - Important Medical Devices Safety Advisory - Tutoplast Dura manufactured by Tutogen Medical GmbHApril 11, 2002 · Medical devices
- Archived - Non-sterile medical devices labeled as sterile manufactured by A & A MedicalMarch 22, 2002 · Medical devices